Mepolizumab for severe refractory eosinophilic asthma: evidence to date and clinical potential
about
Mepolizumab for severe refractory eosinophilic asthma: evidence to date and clinical potential
description
2016 nî lūn-bûn
@nan
2016 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Mepolizumab for severe refract ...... to date and clinical potential
@ast
Mepolizumab for severe refract ...... to date and clinical potential
@en
Mepolizumab for severe refract ...... to date and clinical potential
@nl
type
label
Mepolizumab for severe refract ...... to date and clinical potential
@ast
Mepolizumab for severe refract ...... to date and clinical potential
@en
Mepolizumab for severe refract ...... to date and clinical potential
@nl
prefLabel
Mepolizumab for severe refract ...... to date and clinical potential
@ast
Mepolizumab for severe refract ...... to date and clinical potential
@en
Mepolizumab for severe refract ...... to date and clinical potential
@nl
P2093
P2860
P356
P1476
Mepolizumab for severe refract ...... to date and clinical potential
@en
P2093
Luigi Zucchi
Mirco Lusuardi
Nicola Facciolongo
Sofia Taddei
P2860
P304
P356
10.1177/2040622316659863
P407
P577
2016-08-11T00:00:00Z